Document Type : Original Article(s)


1 Lecturer of Cardiology, Cardiology Department, Assiut University. Cardiology Consultant, Sultan Qaboos Hospital, Oman

2 Cardiology Resident, Assiut General Hospital

3 Clinical Pathology Department, Assiut University

4 Cardiology Department, Assiut University


BACKGROUND: Dyslipidemia is an established risk factor for coronary artery disease (CAD). Despite this, only half of CAD patients present with fasting dyslipidemia. Some reports have linked postprandial lipemia to atherosclerosis. 
We aimed to test the relationship between postprandial lipid profile (after fat loading) and CAD severity assessed by the SYNTAX score.
METHOD: We included 53 patients with documented CADs. We checked both fasting and postprandial (2 hours) lipograms after fat loading with 17 g/body surface area (m2). Then we assessed CAD severity via coronary angiography using the SYNTAX score. Our study is registered in (NCT03175393).
RESULTS: 53 patients with age 57.9 ± 7.82   were recuirted.  36 (68% ) of them were male .We observed a significant increase in postprandial triglycerides (TGs) (154.3 ±73.2 vs. 128.1 ± 69.4 mg/dl; P < 0.001), very-low-density lipoproteins (VLDL) (30.8 ± 14.6 vs. 25.6 ± 13.9 mg/dl; P < 0.001) as well as a significant decrease in the postprandial level of total cholesterol (162.4 ± 45.9 vs. 168.3 ± 46.0 mg/dl; P = 0.03) in comparison to their fasting level. 
We found that the SYNTAX score had a significant positive moderate correlation with 2-hour postprandial TGs (r = 0.55; P < 0.001) and 2-hour postprandial VLDL (r = 0.50; P < 0.001).
Based on the current study, predictors of high Syntax score were older age OR: 1.23(1.11-3.47; P< 0.001) post-prandial triglyceride 2.34 (1.89-5.66; P< 0.001) and post-prandial VLDL 1.76 (1.50-3.49; P< 0.001).
CONCLUSION: Postprandial lipograms, especially TGs, are significantly and positively related to CAD severity. 


  1. Tomaniak M, Katagiri Y, Modolo R, de Silva R, Khamis RY, Bourantas CV, et al. Vulnerable plaques and patients: state-of-the-art. Eur Heart J. 2020;41(31):2997-3004.
  2. Khan MA, Hashim MJ, Mustafa H, Baniyas MY, Al Suwaidi S, AlKatheeri R, et al. Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study. Cureus. 2020;12(7).
  3. O’Malley PG, Arnold MJ, Kelley C, Spacek L, Buelt A, Natarajan S, et al. Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline. Ann Intern Med. 2020;173(10):822-9.
  4. Mach F, Baigent C, Catapano AL, Koskinas KC, Casula M, Badimon L, et al. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS). European Heart Journal. 2019;41(1):111-88.
  5. Kats D, Sharrett AR, Ginsberg HN, Nambi V, Ballantyne CM, Hoogeveen RC, et al. Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study. BMJ Open Diabetes Research & Care. 2017;5(1):e000335.
  6. Katzmann JL, Werner CM, Stojakovic T, März W, Scharnagl H, Laufs U. Apolipoprotein CIII predicts cardiovascular events in patients with coronary artery disease: a prospective observational study. Lipids Health Dis. 2020;19(1):020-01293.
  7. Nakamura A, Sato K, Kanazawa M, Kondo M, Endo H, Takahashi T, et al. Impact of decreased insulin resistance by ezetimibe on postprandial lipid profiles and endothelial functions in obese, non-diabeticmetabolic syndrome patients with coronary artery disease. Heart Vessels. 2019;34(6):916-25.
  8. . !!! INVALID CITATION !!!
  9. Wang F, Wang Y, Zhu Y, Liu X, Xia H, Yang X, et al. Treatment for 6 months with fish oil-derived n-3 polyunsaturated fatty acids has neutral effects on glycemic control but improves dyslipidemia in type 2 diabetic patients with abdominal obesity: a randomized, double-blind, placebo-controlled trial. Eur J Nutr. 2017;56(7):2415-22.
  10. Kannan S, Mahadevan S, Ramji B, Jayapaul M, Kumaravel V. LDL-cholesterol: Friedewald calculated versus direct measurement-study from a large Indian laboratory database. Indian J Endocrinol Metab. 2014;18(4):502-4.
  11. Ikeno F, Brooks MM, Nakagawa K, Kim MK, Kaneda H, Mitsutake Y, et al. SYNTAX Score and Long-Term Outcomes: The BARI-2D Trial. J Am Coll Cardiol. 2017;69(4):395-403.
  12. Safarian H, Alidoosti M, Shafiee A, Salarifar M, Poorhosseini H, Nematipour E. The SYNTAX Score Can Predict Major Adverse Cardiac Events Following Percutaneous Coronary Intervention. Heart Views. 2014;15(4):99-105.
  13. Lund SS, Petersen M, Frandsen M, Smidt UM, Parving H-H, Vaag AA, et al. Agreement between fasting and postprandial LDL cholesterol measured with 3 methods in patients with type 2 diabetes mellitus. Clinical chemistry. 2011;57(2):298-308.
  14. Nordestgaard BG, Benn M, Schnohr P, TybjærgHansen A. Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women. Jama. 2007;298(3):299- 308.
  15. Langsted A, Kamstrup PR, Nordestgaard BG. Lipoprotein (a): fasting and nonfasting levels, inflammation, and cardiovascular risk. Atherosclerosis. 2014;234(1):95-101.
  16. Langsted A, Freiberg J, Nordestgaard B. FASTING VERSUS NON-FASTING LIPID LEVELS-INFLUENCE OF NORMAL FOOD INTAKE ON LIPIDS, LIPOPROTEINS, AND APOLIPOPROTEINS. Atherosclerosis (Supplements)(Component). 2008;1(9):174.
  17. Nordestgaard BG, Benn M. Fasting and nonfasting LDL cholesterol: to measure or calculate? : Oxford University Press; 2009.
  18. Sidhu D, Naugler C. Fasting time and lipid levels in a community-based population: a crosssectional study. Archives of internal medicine. 2012;172(22):1707-10.
  19. Chaturvedi NB, Potdar S, Gurmukhani SN, Patel TM. Evaluation of Lipid Abnormalities (Fasting and Post Prandial) and Its Correlation with Severity of CAD Using SYNTAX Score. Indian Heart Journal. 2019;71:S50.
  20. Ibrahim MM, Ibrahim A, Shaheen K, Nour MA. Lipid profile in Egyptian patients with coronary artery disease. The Egyptian Heart Journal. 15 Sep. 9 ARYA Atheroscler 2022; Volume 18 postprandial lipogram and coronary artery disease 2013;65(2):79-85.
  21. El Kersh AM, Reda AA, El Hadad MG, ElSharnouby KH. Correlation between SYNTAX score and pattern of risk factors in patients referred for coronary angiography in Cardiology Department, Menoufia University. World Journal of Cardiovascular Diseases. 2018;8(8):431-9.
  22. Aguib Y, Al Suwaidi J. The Copenhagen city heart study (Østerbroundersøgelsen). Global Cardiology Science and Practice. 2015;2015(3):33.
  23. Bansal S, Buring JE, Rifai N, Mora S, Sacks FM, Ridker PM. Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women. Jama. 2007;298(3):309-16.
  24. Lindman AS, Veierød M, Tverdal A, Pedersen J, Selmer R. Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study. European journal of epidemiology. 2010;25(11):789-98.
  25. Kats D, Sharrett AR, Ginsberg HN, Nambi V, Ballantyne CM, Hoogeveen RC, et al. Postprandial lipemia and the risk of coronary heart disease and stroke: the Atherosclerosis Risk in Communities (ARIC) Study. BMJ Open Diabetes Research and Care. 2017;5(1).
  26. Manochehri M, Moghadam AJ. Studying the relation of postprandial triglyceride with coronary artery disease (CAD). Medical Archives. 2016;70(4):261.
  27. Sahade V, França S, Adan LF. The influence of weight excess on the postprandial lipemia in adolescents. Lipids in Health and Disease. 2013;12(1):17.
  28. Schauren B, Portal V, Beltrami F, Dos Santos T, Pellanda L. Postprandial metabolism and inflammatory markers in overweight adolescents. Journal of Developmental Origins of Health and Disease. 2014;5(4):299-306.
  29. Collins R, Armitage J. High-risk elderly patients PROSPER from cholesterol-lowering therapy. Lancet. 2002;360(9346).
  30. Iso H, Naito Y, Sato S, Kitamura A, Okamura T, Sankai T, et al. Serum triglycerides and risk of coronary heart disease among Japanese men and women. American journal of epidemiology. 2001;153(5):490-9.